Aug 29
|
Moderna Launches National Awareness Campaign to Help Drive COVID-19 Vaccination
|
Aug 28
|
Moderna, Inc. (MRNA): Among The Best Medical AI Companies
|
Jul 29
|
5 Biotech Stocks to Bet On Bright Industry Prospects
|
Jul 29
|
Exploring Analyst Estimates for Moderna (MRNA) Q2 Earnings, Beyond Revenue and EPS
|
Jul 29
|
RSV vaccine makers vying for market share in second year of shots
|
Jul 26
|
Moderna (MRNA) Stock Before Q2 Earnings: To Buy or Not to Buy?
|
Jul 26
|
Beam Therapeutics (BEAM) Soars 7.9%: Is Further Upside Left in the Stock?
|
Jul 26
|
Moderna Insiders Sell US$3.3m Of Stock, Possibly Signalling Caution
|
Jul 26
|
This Biotech Risk-Taker Created Moderna. Now He’s Harnessing AI.
|
Jul 24
|
Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board
|
Jul 23
|
David Rubenstein Joins Moderna's Board of Directors
|
Jun 27
|
Moderna (MRNA) Shares Decline on RSV Vaccine Efficacy Data
|
Jun 27
|
RSV vaccine makers’ shares fall as CDC adjusts shot guidance
|
Jun 27
|
2 Stocks Down More Than 30% to Buy Right Now
|
Jun 26
|
How consumer spending, election impact markets: Market Domination
|
Jun 26
|
Moderna, Pfizer, and GSK Stocks Fall After Vote on RSV Shots
|
Jun 26
|
Moderna Dives 11% After RSV Vaccine Proves Less Effective Than Pfizer, GSK Shots
|
Jun 26
|
US Equities Markets Close Higher Wednesday as Markets Review New Home Sales Data
|
Jun 26
|
Moderna stock dips on 50% RSV vaccine efficacy after 18 months
|
Jun 26
|
Lilly joins fellow pharma giants in OpenAI partnership
|